UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                     FORM 8K

                                 CURRENT REPORT


     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934




       Date of Report (Date of earliest event reported): December 6, 1999




                              U.S. Microbics, Inc.
               ----------------------------------------------------
             (Exact name of registrant as specified in its charter)



        Colorado                      0-14213                    84-0990371
-------------------------      ----------------------        ------------------
 (State or other juri-        (Commission File Number)         (IRS Employer
diction of incorporation)                                    Identification No.)



                             5922-B Farnsworth Court
                               Carlsbad, CA 92008
               -------------------------------------------------
              (address of principal executive offices and zip code)



        Registrant's telephone number, including area code:(760)918-1860

        Former name or former address, if changed since last report: N/A


<PAGE>



Item 4. Changes in Registrant's Certifying Accountant

Registrant has re-engaged Bradshaw Smith & Co.LLP, as its independent certifying
accountant effective November 22, 1999, dismissing Arthur Andersen LLP its prior
independent  certifying  accountant,   as  of  the  same  date.  The  change  in
independent  certifying accountant was approved by the Board of Directors of the
Registrant on November 22, 1999.

     Arthur Andersen LLP was engaged as the Company's auditors on March 12,
1999. Arthur Andersen LLP has performed tax services for the Registrant during
the interim period of time. The Registrant's dismissal of Arthur Andersen LLP
was part of the Registrant's cost reduction program.

(a)   Exhibit 16.1

     Letter from Arthur Andersen LLP to the Securities and Exchange Commission
dated, December 6th, 1999.


                                    SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.


                                    U.S. Microbics, Inc.

Date: December 6, 1999              By:  /s/ Robert C. Brehm
                                         --------------------------------------
                                         Robert C. Brehm, President and
                                         Chief Executive Officer


                                     By: /s/ Conrad Nagel
                                         --------------------------------------
                                         Conrad Nagel, Chief Financial Officer
[{"type": "8-K", "sequence": "1", "description": "FORM 8-K", "secsgml_size_bytes": 2906}]
{"company-data": {"conformed-name": "US MICROBICS INC", "cik": "0000774454", "assigned-sic": "4899", "irs-number": "840990371", "state-of-incorporation": "CO", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-14213", "film-number": "99772597"}, "business-address": {"street1": "5922 B FARNSWORTH COURT", "city": "CARLSBAD", "state": "CA", "zip": "92008", "phone": "7075739946"}, "mail-address": {"street1": "5922 B FARNSWORTH COURT", "city": "CARLSBAD", "state": "CA", "zip": "92009"}, "former-company": [{"former-conformed-name": "GLOBAL VENTURE FUNDING INC", "date-changed": "19930621"}, {"former-conformed-name": "VENTURE FUNDING CORP", "date-changed": "19920703"}]}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                     FORM 8K

                                 CURRENT REPORT

     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

       Date of Report (Date of earliest event reported): December 6, 1999

                              U.S. Microbics, Inc.
               ----------------------------------------------------
             (Exact name of registrant as specified in its charter)

        Colorado                      0-14213                    84-0990371
-------------------------      ----------------------        ------------------
 (State or other juri-        (Commission File Number)         (IRS Employer
diction of incorporation)                                    Identification No.)

                             5922-B Farnsworth Court
                               Carlsbad, CA 92008
               -------------------------------------------------
              (address of principal executive offices and zip code)

        Registrant's telephone number, including area code:(760)918-1860

        Former name or former address, if changed since last report: N/A
Item 4. Changes in Registrant's Certifying Accountant

Registrant has re-engaged Bradshaw Smith & Co.LLP, as its independent certifying
accountant effective November 22, 1999, dismissing Arthur Andersen LLP its prior
independent  certifying  accountant,   as  of  the  same  date.  The  change  in
independent  certifying accountant was approved by the Board of Directors of the
Registrant on November 22, 1999.

     Arthur Andersen LLP was engaged as the Company's auditors on March 12,
1999. Arthur Andersen LLP has performed tax services for the Registrant during
the interim period of time. The Registrant's dismissal of Arthur Andersen LLP
was part of the Registrant's cost reduction program.

(a)   Exhibit 16.1

     Letter from Arthur Andersen LLP to the Securities and Exchange Commission
dated, December 6th, 1999.

                                    SIGNATURE

     Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.

                                    U.S. Microbics, Inc.

Date: December 6, 1999              By:  /s/ Robert C. Brehm
                                         --------------------------------------
                                         Robert C. Brehm, President and
                                         Chief Executive Officer

                                     By: /s/ Conrad Nagel
                                         --------------------------------------
                                         Conrad Nagel, Chief Financial Officer